Low Use of Opioid Risk Reduction Strategies in Primary Care Even for High Risk Patients with Chronic Pain
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Experts recommend close oversight of patients receiving opioid analgesics for chronic non-cancer pain (CNCP), especially those at increased risk of misuse. We hypothesized that physicians employ opioid risk reduction strategies more frequently in higher risk patients.
Retrospective cohort using electronic medical records.
Patients on long-term opioids (≥3 monthly prescriptions in 6 months) treated for CNCP in eight primary care practices.
We examined three risk reduction strategies: (1) any urine drug test; (2) regular office visits (at least once per 6 months and within 30 days of modifying opioid treatment); and (3) restricted early refills (one or fewer opioid refills more than a week early). Risk factors for opioid misuse included: age <45 years old, drug or alcohol use disorder, tobacco use, or mental health disorder. Associations of risk factors with each outcome were assessed in non-linear mixed effects models adjusting for patient clustering within physicians, demographics and clinical factors.
Of 1,612 patients, 8.0% had urine drug testing, 49.8% visited the office regularly, and 76.6% received restricted (one or fewer) early refills. Patient risk factors were: age <45 (29%), drug use disorder (7.6%), alcohol use disorder (4.5%), tobacco use (16.1%), and mental health disorder (48.4%). Adjusted odds ratios (AOR) of urine drug testing were significantly increased for patients with a drug use disorder (3.18; CI 1.94, 5.21) or a mental health disorder (1.73; CI 1.14, 2.65). However, the AOR for restricted early refills was significantly decreased for patients with a drug use disorder (0.56; CI 0.34, 0.92). After adjustment, no risk factor was significantly associated with regular office visits. An increasing number of risk factors was positively associated with urine drug testing (p < 0.001), but negatively associated with restricted early refills (p = 0.009).
Primary care physicians’ adoption of opioid risk reduction strategies is limited, even among patients at increased risk of misuse.
- Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: Patterns and trends in nonmedical prescription pain reliever use: 2002 to 2005. Rockland, MD.; (April 6, 2007): Accessed on January 20, 2011. Available from: http://oas.samhsa.gov/2k7/pain/pain.pdf
- Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS) Highlights-- 2006 National Admissions to Substance Abuse Treatment Services. OAS Series #S-40, DHHS Publication No. (SMA) 08-4313, Rockville, MD, 2007.
- Centers for Disease Control and Prevention. Unintentional Poisoning Deaths-- United States, 1999-2004. MMWR Morb Mortal Wkly Rep [serial on the Internet]. 56(5): Available from: Accessed on January 20 2011. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5605a1.htm.
- Paulozzi, LJ, Budnitz, DS, Xi, Y (2006) Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 15: pp. 618-27 CrossRef
- Caudill-Slosberg, MA, Schwartz, LM, Woloshin, S (2004) Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 109: pp. 514-9 CrossRef
- A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 13: pp. 6-8 CrossRef
- Federation of State Medical Boards of the United States. Model policy for the use of controlled substances for the treatment of pain. 2004.
- Chou, R, Fanciullo, GJ, Fine, PG, Adler, JA, Ballantyne, JC, Davies, P, Donovan, MI, Fishbain, DA, Foley, KM, Fudin, J, Gilson, AM, Kelter, A, Mauskop, A, O'Connor, PG, Passik, SD, Pasternak, GW, Portenoy, RK, Rich, BA, Roberts, RG, Todd, KH, Miaskowski, C (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10: pp. 113-30 CrossRef
- Sundwall DN, Rolfs RT, Johnson E. Utah Department of Health. Utah Clinical Guidelines of Prescribing Opioids for Treatment of Chronic Pain (2009). Salt Lake City, UT. Accessed January 20 2011. Available from: http://www.dopl.utah.gov/licensing/forms/OpioidGuidlines_summary.pdf.
- Denisco, RA, Chandler, RK, Compton, WM (2008) Addressing the intersecting problems of opioid misuse and chronic pain treatment. Exp Clin Psychopharmacol 16: pp. 417-28 CrossRef
- Starrels, JL, Becker, WC, Alford, DA, Williams, AR, Kapoor, A, Turner, BJ (2010) Opioid treatment agreements and urine drug testing in chronic pain: a systematic review. Ann Intern Med 152: pp. 712-20
- Chou, R, Ballantyne, JC, Fanciullo, GJ, Fine, PG, Miaskowski, C (2009) Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 10: pp. 147-59 CrossRef
- Gourlay, DL, Heit, HA, Almahrezi, A (2005) Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med 6: pp. 107-12 CrossRef
- Ives, TJ, Chelminski, PR, Hammett-Stabler, CA, Malone, RM, Perhac, JS, Potisek, NM, Shilliday, BB, DeWalt, DA, Pignone, MP (2006) Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 6: pp. 46 CrossRef
- Edlund, MJ, Steffick, D, Hudson, T, Harris, KM, Sullivan, M (2007) Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 129: pp. 355-62 CrossRef
- Michna, E, Jamison, RN, Pham, L-D, Ross, EL, Janfaza, D, Nedeljkovic, SS, Narang, S, Palombi, D, Wasan, AD (2007) Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain 23: pp. 173-9 CrossRef
- Reid, MC, Engles-Horton, LL, Weber, MB, Kerns, RD, Rogers, EL, O'Connor, PG (2002) Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 17: pp. 173-9 CrossRef
- White, AG, Birnbaum, HG, Schiller, M, Tang, J, Katz, NP (2009) Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care 15: pp. 897-906
- Hall, AJ, Logan, JE, Toblin, RL, Kaplan, JA, Kraner, JC, Bixler, D, Crosby, AE, Paulozzi, LJ (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 300: pp. 2613-20 CrossRef
- Morasco, BJ, Dobscha, SK (2008) Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry 30: pp. 93-9 CrossRef
- Michna, E, Ross, EL, Hynes, WL, Nedeljkovic, SS, Soumekh, S, Janfaza, D, Palombi, D, Jamison, RN (2004) Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage 28: pp. 250-8 CrossRef
- Wasan, AD, Butler, SF, Budman, SH, Benoit, C, Fernandez, K, Jamison, RN (2007) Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 23: pp. 307-15 CrossRef
- Dunn, KM, Saunders, KW, Rutter, CM, Banta-Green, CJ, Merrill, JO, Sullivan, MD, Weisner, CM, Silverberg, MJ, Campbell, CI, Psaty, BM, Korff, M (2010) Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 152: pp. 85-92
- Yanni, LM, Weaver, MF, Johnson, BA, Morgan, LA, Harrington, SE, Ketchum, JM (2008) Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic. J Opioid Manag 4: pp. 201-11
- Akbik, H, Butler, SF, Budman, SH, Fernandez, K, Katz, NP, Jamison, RN (2006) Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 32: pp. 287-93 CrossRef
- U.S. Census Bureau; Census 2000, Summary File 3; generated by Joanna Starrels; using American FactFinder >http://factfinder.census.gov/>; (11 June 2008)
- Elixhauser, A, Steiner, C, Harris, DR, Coffey, RM (1998) Comorbidity measures for use with administrative data. Med Care 36: pp. 8-27 CrossRef
- Turner, BJ, Hollenbeak, CS, Weiner, M, Have, T, Tang, SS (2008) Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med 148: pp. 578-86
- Agresti, A (2002) Categorical Data Analysis. John Wiley & Sons, Inc, Hoboken, NJ CrossRef
- Adams, NJ, Plane, MB, Fleming, MF, Mundt, MP, Saunders, LA, Stauffacher, EA (2001) Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage 22: pp. 791-6 CrossRef
- Bhamb, B, Brown, D, Hariharan, J, Anderson, J, Balousek, S, Fleming, MF (2006) Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 22: pp. 1859-65 CrossRef
- Boulanger, A, Clark, AJ, Squire, P, Cui, E, Horbay, GLA (2007) Chronic pain in Canada: Have we improved our management of chronic noncancer pain?. Pain Res Manage 12: pp. 39-47
- Touchet, BK, Yates, WR, Coon, KA (2005) Opioid contract use is associated with physician training level and practice specialty. J Opioid Manage 1: pp. 195-200
- Watkins, A, Wasmann, S, Dodson, L, Hayes, M (2004) An evaluation of the care provided to patients prescribed controlled substances for chronic nonmalignant pain at an academic family medicine center. Fam Med 36: pp. 487-9
- Reisfield GM, Webb FJ, Bertholf RL, Sloan PA, Wilson GR. Family physicians' proficiency in urine drug test interpretation. J Opioid Manage. 2007;3(6).
- Tellioglu, T (2008) The use of urine drug testing to monitor patients receiving chronic opioid therapy for persistent pain conditions. Med Health R I 91: pp. 279-80
- Swanson, J (2002) Urine drug screening for opioids. J Pain Palliat Care Pharmacother 16: pp. 111-4 CrossRef
- Katz, NP, Sherburne, S, Beach, M, Rose, RJ, Vielguth, J, Bradley, J, Fanciullo, GJ (2003) Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 97: pp. 1097-102 CrossRef
- Fishbain, DA, Cutler, RB, Rosomoff, HL, Rosomoff, RS (1999) Validity of self-reported drug use in chronic pain patients. Clin J Pain 15: pp. 184-91 CrossRef
- Atluri, S, Sudarshan, G (2003) Evaluation of abnormal urine drug screens among patients with chronic non-malignant pain treated with opioids. Pain Physician 6: pp. 407-9
- Heit, HA, Gourlay, DL (2004) Urine drug testing in pain medicine. J Pain Symptom Manage 27: pp. 260-7 CrossRef
- Sampson, JM, Achololnu, WW (2004) Reducing patient aggression and hostility in primary care with urine drug testing. South Med J 97: pp. 916-7 CrossRef
- Institute for Clinical Systems Improvement. Assessment and management of chronic pain: percentage of patients diagnosed with chronic pain who are prescribed an opioid who have an opioid agreement form and urine toxicology screen documented in the medical record (July 2008). Bloomington, MN.: Accessed on January 20 2011. Available from: http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=13005&string=urine±AND±pain.
- Fleming, MF, Balousek, SL, Klessig, CL, Mundt, MP, Brown, DD (2007) Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 8: pp. 573-82
- Weisner, CM, Campbell, CI, Ray, GT, Saunders, K, Merrill, JO, Banta-Green, C, Sullivan, MD, Silverberg, MJ, Mertens, JR, Boudreau, D, Korff, M (2009) Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 145: pp. 287-93 CrossRef
- Savage, SR, Kirsh, KL, Passik, SD (2008) Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract 4: pp. 4-25 CrossRef
- Compton, PA, Wu, SM, Schieffer, B, Pham, Q, Naliboff, BD (2008) Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage 36: pp. 383-95 CrossRef
- Webster, LR, Webster, RM (2005) Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 6: pp. 432-42 CrossRef
- Holmes, CP, Gatchel, RJ, Adams, LL, Stowell, AW, Hatten, A, Noe, C, Lou, L (2006) An opioid screening instrument: long-term evaluation of the utility of the Pain Medication Questionnaire. Pain Pract 6: pp. 74-88 CrossRef
- Belgrade, MJ, Schamber, CD, Lindgren, BR (2006) The DIRE Score: Predicting Outcomes of Opioid Prescribing for Chronic Pain. J Pain 7: pp. 671-81 CrossRef
- Fishman, SM, Bandman, TB, Edwards, A, Borsook, D (1999) The opioid contract in the management of chronic pain. J Pain Symptom Manage 18: pp. 27-37 CrossRef
- Wiedemer, NL, Harden, PS, Arndt, IO, Gallagher, RM (2007) The opioid renewal clinic: A primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med 8: pp. 573-84 CrossRef
- Low Use of Opioid Risk Reduction Strategies in Primary Care Even for High Risk Patients with Chronic Pain
Journal of General Internal Medicine
Volume 26, Issue 9 , pp 958-964
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- opioid misuse
- chronic pain
- urine drug testing
- Industry Sectors
- Author Affiliations
- 1. Division of General Internal Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, 111 E. 210th Street, Bronx, NY, 10467, USA
- 2. Yale University School of Medicine, New Haven, CT, USA
- 3. University of Pennsylvania School of Medicine, Philadelphia, PA, USA
- 4. University of Texas Health Science Center and University Health System, San Antonio, TX, USA